China is a very complex market with mostly regional market access activities.
At the national level, only the scope of covered services is determined. The detailed scope of services and detailed benefit catalogs are established at the level of local administrative units (provinces and cities).
In out-patient settings, a fee for service model is used for reimbursement of services and in-vitro diagnostic tests.
We offer a seminar on critical elements of the reimbursement system for IVD tests in China, that can guide your decision-making about the introduction of novel technologies into this market. The seminar discusses key stakeholders, money flow, reimbursement in ambulatory settings for IVD tests, national and regional Benefit Catalogs and the role of HTA for market access of IVD tests.
Learn more and get a quote here.